David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
3326
DELISTED
Apellis Pharmaceuticals
APLS
| $638K | ﹤0.01% |
+20,000
| New | +$601K |
|
3327
CALL
Ciena
CIEN
$54.9B
| $636K | ﹤0.01% |
+7,500
| New | +$538K |
|
3328
CALL
SM Energy
SM
$8.49B
| $636K | ﹤0.01% |
16,400
+6,000
| +58% | +$253K |
|
|
BBUC
3329
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.81B
| $635K | ﹤0.01% |
26,175
+3,117
| +14% | +$79.5K |
|
3330
Haleon
HLN
$44.8B
| $634K | ﹤0.01% |
66,458
-339,059
| -84% | -$3.32M |
|
3331
PUT
Annaly Capital Management
NLY
$17.4B
| $633K | ﹤0.01% |
34,600
+18,900
| +120% | +$369K |
|
3332
Costamare
CMRE
$1.91B
| $633K | ﹤0.01% |
+49,247
| New | +$678K |
|
3333
PUT
Perion Network
PERI
$385M
| $633K | ﹤0.01% |
74,700
| – | – |
|
|
ARIS
3334
Aris Mining
ARIS
$4.37B
| $632K | ﹤0.01% |
180,300
-35,600
| -16% | -$148K |
|
|
DOO
3335
PUT
Bombardier Recreational Products
DOO
$4.52B
| $631K | ﹤0.01% |
+12,400
| New | +$644K |
|
3336
PUT
TechnipFMC
FTI
$29.5B
| $631K | ﹤0.01% |
+21,800
| New | +$621K |
|
3337
CALL
Rio Tinto
RIO
$174B
| $629K | ﹤0.01% |
10,700
+100
| +0.9% | +$6.39K |
|
3338
Conagra Brands
CAG
$7.81B
| $628K | ﹤0.01% |
+22,638
| New | +$643K |
|
3339
e.l.f. Beauty
ELF
$6.24B
| $628K | ﹤0.01% |
5,000
-73,408
| -94% | -$8.8M |
|
3340
PUT
Boston Properties
BXP
$11.5B
| $625K | ﹤0.01% |
+8,400
| New | +$681K |
|
3341
PUT
Jack in the Box
JACK
$320M
| $625K | ﹤0.01% |
15,000
-88,500
| -86% | -$4.08M |
|
3342
Kite Realty
KRG
$5.3B
| $623K | ﹤0.01% |
24,672
-69,219
| -74% | -$1.82M |
|
3343
Invesco S&P MidCap 400 Pure Value ETF
RFV
$337M
| $623K | ﹤0.01% |
5,133
| – | – |
|
|
KALV
3344
DELISTED
KalVista Pharmaceuticals
KALV
| $621K | ﹤0.01% |
73,286
-16,643
| -19% | -$172K |
|
3345
Bridgewater Bancshares
BWB
$589M
| $619K | ﹤0.01% |
45,795
+13,963
| +44% | +$205K |
|
3346
Omega Flex
OFLX
$272M
| $619K | ﹤0.01% |
14,740
-300
| -2% | -$14.6K |
|
3347
Lyell Immunopharma
LYEL
$380M
| $618K | ﹤0.01% |
48,313
+24,682
| +104% | +$489K |
|
3348
CALL
HEICO Corp
HEI
$49.1B
| $618K | ﹤0.01% |
2,600
+1,500
| +136% | +$389K |
|
3349
Vanguard Consumer Staples ETF
VDC
$8.05B
| $616K | ﹤0.01% |
+2,913
| New | +$631K |
|
3350
CALL
RCI Hospitality Holdings
RICK
$232M
| $615K | ﹤0.01% |
10,700
-1,000
| -9% | -$48.8K |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.